中国民间中医医药研究开发协会国际针灸合作委员会
办公地点现在已经搬迁至西城区西直门南小街国英园一号楼824室,
同时为方便大家联系,固定电话已经变更
新号码010—58562339。特此通知。
地址:北京西城区西直门南小街国英园一号楼824室
邮编:100035
电话:010-58562339
传真:010-58562339
邮箱:cngjzj@163.com
网站(点击网址直接链接↓):http://www.cngjzj.com/
博客(点击网址直接链接↓):http://blog.sina.com.cn/cngjzj
交通路线图 (点击观看大图)
从首都机场乘坐机场专线,在东直门站下车换乘地铁2号线开往西直门方向,在西直门站 C 口出站:
1、沿西直门内大街向东直行100米,右拐到西直门南小街,向南步行到丁字路口即到国英园1号楼楼下。
2、向南直行50米,绕过 国二招宾馆 沿着中大安胡同向东到西直门南小街,向南步行到丁字路口即到国英园1号楼楼下。
从首都机场内乘坐机场直达西单的大巴,在西单站下车,乘坐出租车到西直门南小街国英园1号楼。
公交官园站:107路,运通106路
公交西直门南:387路,44路,800内环,816路,820内环,845路
地铁车公庄:地铁二号线
地铁西直门:地铁二号线
公交车公庄东:107路,118路,701路
公交车公庄北:209路,375路,392路
您现在的位置是:
首页 >>
R&Dplatform >>
R&Dplatform
2014年10月17日
Chongqing independent research and development of new drugs to successful transfer of 9.3 million dollars
On October 15, 2014
Source: China as our - chongqing daily
The original title: independent research and development new drugs of traditional Chinese medicines in our city
"The complex pulse capsule" with 9.3 million yuan transfer success
Report from our correspondent (reporter Zhang also built) on October 14, the reporter learns from the traditional Chinese medicine research institute, four types of new drugs of traditional Chinese medicines by independent research and development of the hospital "after pulse capsule", recently with 9.3 million yuan price approval documents and the related production technology transfer success. This is also the hospital opened since the biggest single drug varieties of intellectual property rights transactions.
According to introducing, "the compound vein capsule" for new capsule, with qi and nourishing Yin, promoting blood circulation to remove blood stasis, calming nerves, sedative effect and so on, can be used for the palpitation, the palpitation, pulse generation, the symptom such as arrhythmia, and non-toxic side effects. The drug in 2003 the new drug certificates and drug approval number, and in 2005 to obtain national invention patent license.
"Although from approved has been more than 10 years, but the market development ability, production conditions, the court system factors such as limit, the product has not been listed." City in charge of traditional Chinese medicine research institute said that in order to speed up the transformation of scientific and technological achievements, to achieve greater economic and social benefits, in early September this year, the drug into chongqing listing and trading on a stock exchange, and ultimately by hunan Fang Cheng pharmaceutical co., LTD. Successful delisting, and signed a formal contract with the hospital. According to the current transaction of 9.3 million yuan has been delivered, technology transfer, etc. Work is under way.
The original link: http://cq.ifeng.com/economy/news/detail-1_2014_10/15/3015085_0.shtml